PATENT CLAIM ANALYSIS

Application Number: 16291432
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["424", "442000"]

Abstract:
The invention relates to a composition and a method for manufacturing semi-dry or dry particles containing a mucoadhesive polymer and a bioactive agent such as, but not limited to, an Immunogenic Substance (e.g., a vaccine), that allows the oral or nasal administration and delivery of the bioactive agent essentially unaltered to mucosal surfaces in the animal, including an aquatic animal.

Claim (Index 3):
The immunogenic substance of  claim 1 , wherein the vaccine is selected from the group consisting of (a) recombinant vectors comprising a gene encoding an immunogenic protein, (b) intact inactive, attenuated or infectious viral particles, (c) intact killed, attenuated or infectious prokaryotes, (d) intact killed, attenuated or infectious protozoans, and (e) intact killed, attenuated or infectious multicellular pathogens.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 99.0
- Lexical Diversity: 1.38776
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13260661', '14305406', '13466279', '13204745', '12409607']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6757093566717618
- 35 USC 102 Novelty (BERT): 0.5859383423150013
- Combined Prediction Score: 0.6667322552360857
- Mean Citation Score: 309.9065720000001
- Max Citation Score: 479.5791
- Similarity Product: 433.14196528515816

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test